MedPath
NMPA Approval

Human Papillomavirus (Types 16,18) Vaccine, Adsorbed

国药准字SJ20160025

August 10, 2021

S20160025

Drug Information

双价人乳头瘤病毒吸附疫苗

希瑞适

注射剂

0.5ml/支(含HPV-16 L1蛋白和HPV-18 L1蛋白各20μg)

生物制品

August 10, 2021

August 9, 2026

Company Information

Applicant Company

Rue de l’Institut 89, B-1330 Rixensart, Belgium

Manufacturing Company

Parc de la Noire Epine, Rue Fleming 20, Wavre 1300, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

双价人乳头瘤病毒吸附疫苗 - NMPA 批准文号 | MedPath